{"@id":"https://bioecon.ru/technology/engineered-bacteria-drug-delivery/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/engineered-bacteria-drug-delivery/","json":"https://cn.bioecon.ru/api/v1/technology/engineered-bacteria-drug-delivery/index.json"},"id":"engineered-bacteria-drug-delivery","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/terragia-biofuel-inc/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/syncti-singapore/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/asahi-group-holdings/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/biodxco/"]},"maturity":7,"name":"合成生物学工程化活体细菌实体瘤靶向载药（BRISPR）","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"恶性实体瘤乏氧坏死微环境靶向定植"},{"n":2,"title":"群体感应调控同步脉冲式自发裂解回路"},{"n":3,"title":"高活性治疗性生物大分子胞内蓄积表达"},{"n":4,"title":"肿瘤微环境原位周期性超高浓度释放确证"}],"summary":"基于合成生物学工程化改造的非致病共生益生菌株（如大肠杆菌Nissle 1917），集成群体感应介导的周期性同步裂解自杀回路，特异性定植于实体瘤深部乏氧坏死核心区，原位持续分泌纳米抗体、免疫检查点阻断剂或化疗前药激活酶。","url":"/technology/engineered-bacteria-drug-delivery/","verified":"2026-11-22"}